Home » Topics » Regulatory

Regulatory
RSS

FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis

May 29, 2018

FDA approves Palynziq for adults with phenylketonuria

May 25, 2018

Prolia approved in U.S. for glucocorticoid-induced osteoporosis

May 22, 2018

FDA approves thrombopoietin receptor agonist Doptelet

May 22, 2018

FDA approves Aimovig for prevention of migraine

May 18, 2018

FDA approves Briviact oral formulations for the treatment of pediatric patients

May 15, 2018

FDA approves Gilenya to treat MS in pediatric patients

May 14, 2018

FDA approves Myrbetriq in combination with solifenacin for overactive bladder

May 8, 2018

FDA approves Tafinlar with Mekinist for BRAF-positive anaplastic thyroid cancer

May 7, 2018

FDA approves AndexXa to reverse factor Xa inhibitors

May 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...